Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand "Pfizer for All."
辉瑞公司（纽约证券交易所代码：PFE）希望在其 COVID-19 疫苗推广成功的基础上再接再厉，推出一个以 “辉瑞为所有人” 品牌的直接面向消费者的药品平台。
The move, reflected in a recent trademark application, aims to provide medical information, mail-order pharmacy, and telehealth services to US patients.
此举反映在最近的商标申请中，旨在向美国患者提供医疗信息、邮购药房和远程医疗服务。
Recent reports indicate Pfizer's intention to include various medications, including its COVID antiviral Paxlovid and diagnostic kits, on the platform later this year, expanding its offerings to cater to diverse healthcare needs.
最近的报告表明，辉瑞打算在今年晚些时候在该平台上加入各种药物，包括其COVID抗病毒Paxlovid和诊断试剂盒，扩大其产品范围以满足不同的医疗需求。
Related: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac.
相关： 辉瑞同意解决10,000多起与停产的胃灼热药物Zantac相关的癌症风险的诉讼。
The platform will offer a "downloadable mobile application for providing medical information" as well as "mail order pharmacy services" and "diagnostic test kits . . . for use in disease screening and detection", according to the trademark application, the FT writes.
英国《金融时报》写道，根据商标申请，该平台将提供 “用于提供医疗信息的可下载移动应用程序” 以及 “邮购药房服务” 和 “诊断检测试剂盒。。用于疾病筛查和检测”。
This initiative follows similar endeavors in the pharmaceutical industry to bypass traditional middlemen and directly reach consumers.
该举措是在制药行业采取类似举措之后采取的，旨在绕过传统的中间商，直接接触消费者。
Earlier this year, Eli Lilly And Co (NYSE:LLY) launched its LillyDirect platform, marking an industry first.
今年早些时候，礼来公司（纽约证券交易所代码：LLY）推出了其LillyDirect平台，这标志着业界首创。
The "Pfizer for All" platform is positioned as a healthcare equity endeavor, seeking to simplify the often convoluted process through which US patients obtain their medications, the Financial Times highlights.
《金融时报》强调，“Pfizer for All” 平台被定位为一项医疗保健股权项目，旨在简化美国患者获得药物时经常错综复杂的过程。
Citing the sources familiar with the plans, the FT notes that Pfizer intends to leverage its brand equity gained from its pivotal role in combating the Covid-19 crisis.
英国《金融时报》援引熟悉计划的消息人士的话指出，辉瑞打算利用其在应对Covid-19危机中的关键作用中获得的品牌资产。
Despite Pfizer's favorable reception during the height of the vaccine rollout, its favorability score has experienced fluctuations. The company's stock value has also declined from its pandemic peak, facing skepticism from investors regarding its growth trajectory.
尽管辉瑞在疫苗推出的高峰期受到了好评，但其支持度得分却出现了波动。由于投资者对其增长轨迹持怀疑态度，该公司的股票价值也已从疫情峰值下跌。
However, Timothy Mackey, a professor of global health at the University of California San Diego, believes that Pfizer's approach may resonate positively with consumers despite mixed sentiments surrounding pharmaceutical companies.
但是，加州大学圣地亚哥分校全球健康教授蒂莫西·麦基认为，尽管围绕制药公司的情绪喜忧参半，但辉瑞的做法可能会引起消费者的积极共鸣。
Price Action: PFE shares are up 1.30% at $28.38 at last check Monday.
价格走势：周一最后一次检查时，PFE股价上涨1.30％，至28.38美元。
Photo via Shutterstock
照片来自 Shutterstock